Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
New Housing Starts to Fall to Lowest Level Since 2020
New Housing Starts to Fall to Lowest Level Since 2020
Instacart to Make Market Debut on Nasdaq
Instacart to Make Market Debut on Nasdaq
Canadian Auto Union Extends Strike Deadline By One Day
Canadian Auto Union Extends Strike Deadline By One Day
Sam Bankman-Fried to Argue for Pre-Trial Release
Sam Bankman-Fried to Argue for Pre-Trial Release
Dominion Voting Lawsuit Against Newsmax Trial Date Set
A trial has been set for Dominion Voting Systems' lawsuit against Newsmax over the network's 2020 election misinformation.
Ready4Work Features Advice from Career Coaches
Searching for a job is not easy. Cheddar News' new docuseries "Ready 4 Work," which premieres on Thursday, introduces you to some career coaches to help you make that process easier.
Instacart Launching IPO Tuesday
Instacart's initial public offering was priced at $30 a share, valuing the company at around $10 billion.
X Could Begin Charging for Paid Monthly Subscription
Elon Musk said X could start charging a monthly subscription.
U.S. Debt Surpasses $33 Trillion
The U.S. debt has surpassed $33 trillion for the first time in history.
